PROS1 and Alzheimer disease: Experiments in this study were designed to determine the density and distribution of Aβ and pTau, and the expression of inflammatory proteins, NLRP1, NLRP3, ASC, and caspase‐1 in postmortem human brains with and without intermediate AD neuropathological changes.